Mesa Laboratories Statistics
Total Valuation
MLAB has a market cap or net worth of $339.22 million. The enterprise value is $501.14 million.
Important Dates
The next estimated earnings date is Thursday, November 6, 2025, before market open.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | Aug 29, 2025 |
Share Statistics
MLAB has 5.50 million shares outstanding. The number of shares has increased by 0.85% in one year.
| Current Share Class | 5.50M |
| Shares Outstanding | 5.50M |
| Shares Change (YoY) | +0.85% |
| Shares Change (QoQ) | +2.10% |
| Owned by Insiders (%) | 2.95% |
| Owned by Institutions (%) | 98.19% |
| Float | 5.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 60.26 |
| PS Ratio | 1.38 |
| Forward PS | 1.32 |
| PB Ratio | 1.97 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 10.10 |
| P/OCF Ratio | 8.94 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 12.75, with an EV/FCF ratio of 14.92.
| EV / Earnings | n/a |
| EV / Sales | 2.07 |
| EV / EBITDA | 12.75 |
| EV / EBIT | 35.11 |
| EV / FCF | 14.92 |
Financial Position
The company has a current ratio of 0.66, with a Debt / Equity ratio of 1.07.
| Current Ratio | 0.66 |
| Quick Ratio | 0.42 |
| Debt / Equity | 1.07 |
| Debt / EBITDA | 4.07 |
| Debt / FCF | 5.51 |
| Interest Coverage | 1.27 |
Financial Efficiency
Return on equity (ROE) is -0.38% and return on invested capital (ROIC) is 2.45%.
| Return on Equity (ROE) | -0.38% |
| Return on Assets (ROA) | 2.04% |
| Return on Invested Capital (ROIC) | 2.45% |
| Return on Capital Employed (ROCE) | 4.99% |
| Revenue Per Employee | $331,988 |
| Profits Per Employee | -$849 |
| Employee Count | 730 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 3.05 |
Taxes
In the past 12 months, MLAB has paid $9.69 million in taxes.
| Income Tax | 9.69M |
| Effective Tax Rate | 106.84% |
Stock Price Statistics
The stock price has decreased by -48.51% in the last 52 weeks. The beta is 0.82, so MLAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | -48.51% |
| 50-Day Moving Average | 71.98 |
| 200-Day Moving Average | 110.37 |
| Relative Strength Index (RSI) | 40.85 |
| Average Volume (20 Days) | 118,487 |
Short Selling Information
The latest short interest is 399,329, so 7.26% of the outstanding shares have been sold short.
| Short Interest | 399,329 |
| Short Previous Month | 398,709 |
| Short % of Shares Out | 7.26% |
| Short % of Float | 7.48% |
| Short Ratio (days to cover) | 3.47 |
Income Statement
In the last 12 months, MLAB had revenue of $242.35 million and -$620,000 in losses. Loss per share was -$0.11.
| Revenue | 242.35M |
| Gross Profit | 151.01M |
| Operating Income | 14.27M |
| Pretax Income | -270.81M |
| Net Income | -620,000 |
| EBITDA | 39.29M |
| EBIT | 14.27M |
| Loss Per Share | -$0.11 |
Full Income StatementBalance Sheet
The company has $23.01 million in cash and $184.94 million in debt, giving a net cash position of -$161.93 million or -$29.43 per share.
| Cash & Cash Equivalents | 23.01M |
| Total Debt | 184.94M |
| Net Cash | -161.93M |
| Net Cash Per Share | -$29.43 |
| Equity (Book Value) | 172.50M |
| Book Value Per Share | 31.35 |
| Working Capital | -51.24M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $37.96 million and capital expenditures -$4.37 million, giving a free cash flow of $33.59 million.
| Operating Cash Flow | 37.96M |
| Capital Expenditures | -4.37M |
| Free Cash Flow | 33.59M |
| FCF Per Share | $6.11 |
Full Cash Flow StatementMargins
Gross margin is 62.31%, with operating and profit margins of 5.89% and -0.26%.
| Gross Margin | 62.31% |
| Operating Margin | 5.89% |
| Pretax Margin | 3.74% |
| Profit Margin | -0.26% |
| EBITDA Margin | 16.21% |
| EBIT Margin | 5.89% |
| FCF Margin | 13.86% |
Dividends & Yields
This stock pays an annual dividend of $0.64, which amounts to a dividend yield of 1.04%.
| Dividend Per Share | $0.64 |
| Dividend Yield | 1.04% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.85% |
| Shareholder Yield | 0.19% |
| Earnings Yield | -0.18% |
| FCF Yield | 9.90% |
Dividend DetailsAnalyst Forecast
The average price target for MLAB is $113.50, which is 84.34% higher than the current price. The consensus rating is "Buy".
| Price Target | $113.50 |
| Price Target Difference | 84.34% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MLAB has an Altman Z-Score of 1.43 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.43 |
| Piotroski F-Score | 5 |
